FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297860032> ?p ?o ?g. }

• W4297860032 abstract "Background: Ferroptosis is a newly discovered form of regulated cell death with distinct properties and recognizing functions involved in physical conditions or various diseases, including cancers. However, the relationship between gliomas and ferroptosis-related lncRNAs (FRLs) remains unclear. Methods: We collected a total of 1850 samples from The Cancer Genome Atlas (TCGA) and Genotype Tissue Expression (GTEX) databases, including 698 tumor and 1,152 normal samples. A list of ferroptosis-related genes was downloaded from the Ferrdb website. Differentially expressed FRLs (DEFRLS) were analyzed using the limma package in R software. Subsequently, prognosis-related FRLs were obtained by univariate Cox analysis. Finally, a prognostic model based on the 3 FRLs was constructed using Cox regression analysis with the least absolute shrinkage and selection operator (LASSO) algorithm. The prognostic power of the model was assessed using receiver operating characteristic (ROC) curve analysis and Kaplan-Meier (K-M) survival curve analysis. In addition, we further explored the relationship of the immune landscape and somatic mutations to prognostic model characteristics. Finally, we validated the function of LINC01426 in vitro. Results: We successfully constructed a 3-FRLs signature and classified glioma patients into high-risk and low-risk groups based on the risk score calculated from this signature. Compared with traditional clinicopathological features [age, sex, grade, isocitrate dehydrogenase (IDH) status], the prognostic accuracy of this model is more stable and stronger. Additionally, the model had stable predictive power for overall survival over a 5-year period. In addition, we found significant differences between the two groups in cellular immunity, the numbers of many immune cells, including NK cells, CD4+, CD8+ T-cells, and macrophages, and the expression of many immune-related genes. Finally, the two groups were also significantly different at the level of somatic mutations, especially in glioma prognosis-related genes such as IDH1 and ATRX, with lower mutation rates in the high-risk group leading to poorer prognosis. Finally, we found that the ferroptosis process of glioma cells was inhibited after knocking down the expression of LINC01426. Conclusion: The proposed 3-FRL signature is a promising biomarker for predicting prognostic features in glioma patients." @default.
• W4297860032 created "2022-10-01" @default.
• W4297860032 creator A5009290008 @default.
• W4297860032 creator A5014156111 @default.
• W4297860032 creator A5042026294 @default.
• W4297860032 creator A5044265859 @default.
• W4297860032 creator A5045703368 @default.
• W4297860032 creator A5053447705 @default.
• W4297860032 creator A5083863486 @default.
• W4297860032 creator A5087100663 @default.
• W4297860032 date "2022-09-20" @default.
• W4297860032 modified "2023-09-26" @default.
• W4297860032 title "Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma" @default.
• W4297860032 cites W1979420536 @default.
• W4297860032 cites W1986092833 @default.
• W4297860032 cites W1987592711 @default.
• W4297860032 cites W2055475004 @default.
• W4297860032 cites W2066671159 @default.
• W4297860032 cites W2092979611 @default.
• W4297860032 cites W2096287682 @default.
• W4297860032 cites W2114104545 @default.
• W4297860032 cites W2117553516 @default.
• W4297860032 cites W2126817554 @default.
• W4297860032 cites W2128149258 @default.
• W4297860032 cites W2128619556 @default.
• W4297860032 cites W2130410032 @default.
• W4297860032 cites W2135465849 @default.
• W4297860032 cites W2139658526 @default.
• W4297860032 cites W2146512944 @default.
• W4297860032 cites W2148977460 @default.
• W4297860032 cites W2165438710 @default.
• W4297860032 cites W2204695746 @default.
• W4297860032 cites W2216283224 @default.
• W4297860032 cites W2265062179 @default.
• W4297860032 cites W2292914130 @default.
• W4297860032 cites W2310964761 @default.
• W4297860032 cites W2403400382 @default.
• W4297860032 cites W2560367415 @default.
• W4297860032 cites W2611252724 @default.
• W4297860032 cites W2731227355 @default.
• W4297860032 cites W2744365130 @default.
• W4297860032 cites W2783137027 @default.
• W4297860032 cites W2887975472 @default.
• W4297860032 cites W2888500336 @default.
• W4297860032 cites W2897815318 @default.
• W4297860032 cites W2916543168 @default.
• W4297860032 cites W2935369648 @default.
• W4297860032 cites W2936706033 @default.
• W4297860032 cites W2939322913 @default.
• W4297860032 cites W2940057770 @default.
• W4297860032 cites W2943793201 @default.
• W4297860032 cites W2945161487 @default.
• W4297860032 cites W2975105312 @default.
• W4297860032 cites W2979937337 @default.
• W4297860032 cites W2984537832 @default.
• W4297860032 cites W3003960907 @default.
• W4297860032 cites W3009687707 @default.
• W4297860032 cites W3010860369 @default.
• W4297860032 cites W3012724705 @default.
• W4297860032 cites W3037379313 @default.
• W4297860032 cites W3043061272 @default.
• W4297860032 cites W3044530270 @default.
• W4297860032 cites W3048484045 @default.
• W4297860032 cites W3082933058 @default.
• W4297860032 cites W3108311293 @default.
• W4297860032 cites W3109606946 @default.
• W4297860032 cites W3112333387 @default.
• W4297860032 cites W3127739024 @default.
• W4297860032 cites W3129176329 @default.
• W4297860032 cites W3129779330 @default.
• W4297860032 cites W3154110302 @default.
• W4297860032 cites W3161233656 @default.
• W4297860032 cites W3168617320 @default.
• W4297860032 cites W3175752499 @default.
• W4297860032 cites W3210316066 @default.
• W4297860032 cites W3216859125 @default.
• W4297860032 cites W4200068043 @default.
• W4297860032 cites W4200427964 @default.
• W4297860032 cites W4210635855 @default.
• W4297860032 cites W4211220688 @default.
• W4297860032 cites W4220868538 @default.
• W4297860032 doi "https://doi.org/10.3389/fgene.2022.927142" @default.
• W4297860032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36226186" @default.
• W4297860032 hasPublicationYear "2022" @default.
• W4297860032 type Work @default.
• W4297860032 citedByCount "1" @default.
• W4297860032 countsByYear W42978600322022 @default.
• W4297860032 crossrefType "journal-article" @default.
• W4297860032 hasAuthorship W4297860032A5009290008 @default.
• W4297860032 hasAuthorship W4297860032A5014156111 @default.
• W4297860032 hasAuthorship W4297860032A5042026294 @default.
• W4297860032 hasAuthorship W4297860032A5044265859 @default.
• W4297860032 hasAuthorship W4297860032A5045703368 @default.
• W4297860032 hasAuthorship W4297860032A5053447705 @default.
• W4297860032 hasAuthorship W4297860032A5083863486 @default.
• W4297860032 hasAuthorship W4297860032A5087100663 @default.
• W4297860032 hasBestOaLocation W42978600321 @default.
• W4297860032 hasConcept C10515644 @default.
• W4297860032 hasConcept C119857082 @default.
• W4297860032 hasConcept C126322002 @default.

• next